Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE:002370)

SHE:002370 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	586.46	618.72	743.85	720.47	757.62	821.11
Cash & Short-Term Investments	616.52	618.72	743.85	720.47	757.62	821.11
Cash Growth	-20.63%	-16.82%	3.25%	-4.90%	-7.73%	-9.06%
Accounts Receivable	95.6	155.05	111.68	111.8	115.65	85.24
Other Receivables	30.53	0.53	16.14	29.19	15.14	1.18
Receivables	126.13	155.58	127.82	140.99	130.79	86.42
Inventory	100.94	107.25	70.13	89.47	95.2	60.9
Other Current Assets	14.47	16.72	13.36	4.24	21.23	27.41
Total Current Assets	858.06	898.27	955.16	955.18	1,005	995.85
Property, Plant & Equipment	290.36	294.73	338.11	364.79	385.89	433.99
Long-Term Investments	36.31	38.01	38.49	37.75	40.96	58.27
Other Intangible Assets	42.71	44	54.2	59.21	57.22	51.57
Long-Term Deferred Tax Assets	-	-	-	-	0.25	-
Long-Term Deferred Charges	5.45	4.7	15.82	11.37	22.14	71.1
Other Long-Term Assets	-	-	-	1.08	12.56	-
Total Assets	1,233	1,280	1,402	1,429	1,524	1,611

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	76.84	103.97	45.77	51.8	89.83	53.93
Accrued Expenses	6.19	18.17	17.08	16.98	22.73	21.65
Short-Term Debt	-	-	30.06	50.06	50.06	-
Current Portion of Long-Term Debt	-	-	301.7	-	-	110.16
Current Portion of Leases	-	-	-	-	1.7	1.35
Current Income Taxes Payable	1.63	-	-	-	-	-
Current Unearned Revenue	14.16	14.75	2.23	7.96	14.47	2.77
Other Current Liabilities	9.71	15.36	19.6	35.01	43.58	24.3
Total Current Liabilities	108.53	152.24	416.44	161.8	222.38	214.15
Long-Term Debt	-	-	-	639.48	900.01	861.58
Long-Term Leases	-	-	-	-	-	1.34
Long-Term Unearned Revenue	2.93	3.21	4.36	5.56	6.83	15.16
Long-Term Deferred Tax Liabilities	3.73	3.98	3.86	3.61	3.55	5.94
Other Long-Term Liabilities	-	-	4.93	38.04	89.83	79.65
Total Liabilities	115.18	159.43	429.59	848.5	1,223	1,178

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	745.67	745.67	728.59	609.17	536.69	536.62
Additional Paid-In Capital	2,005	2,005	1,907	1,594	1,310	1,309
Retained Earnings	-1,633	-1,630	-1,727	-1,761	-1,749	-1,616
Comprehensive Income & Other	-	-	63.35	138.8	203.57	203.8
Total Common Equity	1,118	1,120	972.18	580.87	301.27	432.96
Shareholders' Equity	1,118	1,120	972.18	580.87	301.27	432.96
Total Liabilities & Equity	1,233	1,280	1,402	1,429	1,524	1,611

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	-	-	331.75	689.54	951.78	974.43
Net Cash (Debt)	616.52	618.72	412.1	30.94	-194.16	-153.31
Net Cash Growth	29.44%	50.14%	1232.00%	-	-	-
Net Cash Per Share	0.83	0.84	0.60	0.05	-0.37	-0.29
Filing Date Shares Outstanding	745.67	745.67	728.59	609.17	536.69	536.62
Total Common Shares Outstanding	745.67	745.67	728.59	609.17	536.69	536.62
Working Capital	749.53	746.04	538.72	793.38	782.46	781.7
Book Value Per Share	1.50	1.50	1.25	0.72	0.18	0.81
Tangible Book Value	1,075	1,076	917.99	521.67	244.04	381.39
Tangible Book Value Per Share	1.44	1.44	1.17	0.63	0.07	0.71
Buildings	-	371.25	429.39	427.32	413.92	426.8
Machinery	-	179.36	224.35	221.97	220.86	221.01
Construction In Progress	-	0.02	0.03	0.03	-	0.9

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error